What is the share price of Max India Ltd (MAXIND) today?
The share price of MAXIND as on 22nd September 2026 is ₹151.86. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Max India Ltd (MAXIND) share?
The past returns of Max India Ltd (MAXIND) share are- Past 1 week: 1.44%
- Past 1 month: 0.91%
- Past 3 months: -9.08%
- Past 6 months: 9.89%
- Past 1 year: -26.68%
- Past 3 years: 17.37%
- Past 5 years: 122.38%
What are the peers or stocks similar to Max India Ltd (MAXIND)?
The peers or stocks similar to Max India Ltd (MAXIND) include:What is the market cap of Max India Ltd (MAXIND) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Max India Ltd (MAXIND) is ₹855.29 Cr as of 22nd September 2026.What is the 52 week high and low of Max India Ltd (MAXIND) share?
The 52-week high of Max India Ltd (MAXIND) is ₹241.57 and the 52-week low is ₹120.What is the PE and PB ratio of Max India Ltd (MAXIND) stock?
The P/E (price-to-earnings) ratio of Max India Ltd (MAXIND) is -7.02. The P/B (price-to-book) ratio is 2.09.Which sector does Max India Ltd (MAXIND) belong to?
Max India Ltd (MAXIND) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Max India Ltd (MAXIND) shares?
You can directly buy Max India Ltd (MAXIND) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Max India Ltd
MAXIND Share Price
NSEMAXIND Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MAXIND Performance & Key Metrics
MAXIND Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -6.46 | 2.09 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.38 | 5.94 | 0.48% |
MAXIND Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
MAXIND Company Profile
Max India Limited operates in the health and allied services space. The Company’s operating businesses include: Max Healthcare Institute Limited, Max Bupa Health Insurance Company Limited, Antara Senior Living Limited and Max SkillFirst Limited.
MAXIND Sentiment Analysis
MAXIND Sentiment Analysis
MAXIND Stock Summary · August 2026
Management said the quarter was marked by strong operating progress, even as timing shifts and cost pressures kept profitability under pressure. In senior living, possession offers were issued to all 340 Noida residents, about INR169 crores of demand was raised, and roughly 75% of dues has already been collected, setting up the first NCR community to come online within weeks; revenue recognition, however, will follow possession rather than cash collection. Assisted care also moved forward, with all eight centers now operating and revenue reaching INR12.03 crores in Q1 FY27 as occupied bed days rose 23% quarter on quarter. In parallel, AGEasy scaled to a near INR120 crores annualized run rate, while July marketplace margins improved sharply, reflecting better ad efficiency. Management stressed capital discipline, saying fundraising has been deferred and incremental capital needs have fallen to about $20 million over two years. They also noted margin headwinds from logistics, airfreight, manpower inflation and the loss of an exceptional fee. Near term, the company expects Noida recognition and write-offs in Q2 and said clearer evidence of profitability should emerge over the next two quarters.
MAXIND Stock Growth Drivers
MAXIND Stock Growth Drivers
7Strong Execution and Operational Milestones in Senior Living
The company delivered a meaningful operational breakthrough in senior living, led by the possession handover
Expansion and Profitability Progress in Care Homes
The care home platform showed broad-based improvement, with all eight centers operational after the relaunch
MAXIND Stock Challenges
MAXIND Stock Challenges
5Supply-Chain and Logistics Cost Pressure
The company is facing persistent supply-chain disruption that is raising costs and complicating working capital
Profitability Remains Under Pressure
Consolidated profitability weakened in the latest quarter, with EBITDA loss widening to INR25 crores in
MAXIND Forecast
MAXIND Forecasts
MAXIND
MAXIND
Income
Balance Sheet
Cash Flow
MAXIND Income Statement
MAXIND Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 49.68 | 32.95 | 48.23 | 39.64 | 45.47 | 49.22 | 50.17 | 49.81 | 72.04 | 68.62 | ||||||||||
| Operating & Other expenses | 67.01 | 55.89 | 65.62 | 79.02 | 85.52 | 68.11 | 80.26 | 85.14 | 83.60 | 96.84 | ||||||||||
| EBITDA | -17.33 | -22.94 | -17.39 | -39.38 | -40.05 | -18.89 | -30.09 | -35.33 | -11.56 | -28.22 | ||||||||||
| Depreciation/Amortization | 2.98 | 3.93 | 4.61 | 5.03 | 5.25 | 5.77 | 5.94 | 6.09 | 7.30 | 7.37 | ||||||||||
| PBIT | -20.31 | -26.87 | -22.00 | -44.41 | -45.30 | -24.66 | -36.03 | -41.42 | -18.86 | -35.59 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -20.31 | -26.87 | -22.00 | -44.41 | -45.30 | -24.66 | -36.03 | -41.42 | -18.86 | -35.59 | ||||||||||
| Taxes & Other Items | 1.26 | 0.10 | 0.73 | 0.19 | 0.79 | 0.98 | -1.96 | 1.43 | 0.43 | 0.69 | ||||||||||
| Net Income | -21.57 | -26.97 | -22.73 | -44.60 | -46.09 | -25.64 | -34.07 | -42.85 | -19.29 | -36.28 | ||||||||||
| EPS | -4.72 | -5.90 | -4.98 | -9.47 | -10.08 | -5.44 | -6.52 | -8.17 | -3.67 | -6.91 |
MAXIND Company Updates
Investor Presentation
MAXIND Stock Peers
MAXIND Past Performance & Peer Comparison
MAXIND Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Max India Ltd | -7.02 | 2.09 | — |
| Apollo Hospitals Enterprise Limited | 65.43 | 12.73 | 0.23% |
| Max Healthcare Institute Limited | 71.29 | 9.57 | 0.19% |
| Manipal Health Enterprises Limited | 109.98 | 11.15 | — |
MAXIND Stock Price Comparison
Compare MAXIND with any stock or ETFMAXIND Holdings
MAXIND Shareholdings
MAXIND Promoter Holdings Trend
MAXIND Promoter Holdings Trend
In last 6 months, promoter holding in the company has decreased by 1.50%
Pledged promoter holdings is insignificant
MAXIND Institutional Holdings Trend
MAXIND Institutional Holdings Trend
In last 3 months, retail holding in the company has decreased by 1.12%
In last 3 months, foreign institutional holding of the company has almost stayed constant
MAXIND Shareholding Pattern
MAXIND Shareholding Pattern
MAXIND Shareholding History
MAXIND Shareholding History
smallcases containing MAXIND stock
smallcases containing MAXIND stock
Looks like this stock is not in any smallcase yet.
MAXIND Events
MAXIND Events
MAXIND Dividend Trend
MAXIND has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
MAXIND Dividend Trend
MAXIND has not given any dividends in last 5 years
MAXIND Dividends
MAXIND Dividends
MAXIND Stock News & Opinions
MAXIND Stock News & Opinions
Max India Ltd share price slipped 1.42% to Rs 169.85 after the company's net profit surged by 88.08% to Rs 36.28 crore, while revenue from operations eased by 8.97% to Rs 59.74 crore in Q2FY26 over Q1FY26. The market capitalization of Holding Company industry group stocks on BSE stood at Rs 4.44 lakh crore, rising 0.86%. It has softened by 1.88% over last one week and advanced by 14.51% in last one month while the market capitalization of Max India Ltd has inched up 0.21% and 10.06% in the same period respectively. Profit before tax (PBT) of Max India Ltd stood at Rs 35.59 crore in Q2 FY26, surging by 44.32% year-on-year, and jumping 88.71% quarter-on-quarter. EBITDA came in at Rs 45 crore, rallying 26.03% YoY and expanding by 102.86% sequentially. Total expenses increased by 16.58% to Rs 103.65 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 13.14 crore, increasing 16.90% YoY, while employee benefits expense was at Rs 25.43 crore, soaring 31.76% YoY. For the TTM ended FY26, revenue from operations surged 30.98% to Rs 190.56 crore, while net profit fell 13.21% to Rs 121.85 crore, compared to previous TTM. EBITDA tanked by 13964% to Rs 142.45 crore, and PBT contracted 12.71% to Rs 120.97 crore compared to previous TTM. Max India Ltd tumbled by 17.65% in last one year, underperforming the benchmark BSE Sensex which has slipped by 2.56% during the same period.
Max India Limited will hold a board meeting on Tuesday, August 11, 2026, to consider the unaudited financial results for both standalone and consolidated entities for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. Trading window for designated persons and their immediate relatives will remain closed until Thursday, August 13, 2026, as per the company's insider trading policy.
Max India Limited announced that its Nomination and Remuneration Committee approved the allotment of 118,222 equity shares with a face value of Rs 10 each to eligible employees and subsidiaries, following the exercise of vested stock options under the Employee Stock Option Plan, 2020. Consequently, the company's issued, subscribed, and paid-up capital increased from Rs 56,20,24,560 comprising 5,62,02,456 equity shares to Rs 56,32,06,780 comprising 5,63,20,678 equity shares, as disclosed on August 5, 2026.
Max India announced that the 7th Annual General Meeting(AGM) of the company will be held on 19 August 2026.
Net Loss of Max India reported to Rs 19.29 crore in the quarter ended March 2026 as against net loss of Rs 46.09 crore during the previous quarter ended March 2025. Sales rose 58.07% to Rs 65.63 crore in the quarter ended March 2026 as against Rs 41.52 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 121.85 crore in the year ended March 2026 as against net loss of Rs 140.39 crore during the previous year ended March 2025. Sales rose 30.98% to Rs 190.56 crore in the year ended March 2026 as against Rs 145.49 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales65.6341.52 58 190.56145.49 31 OPM %-22.87-98.31 --57.63-81.23 - PBDT-11.36-39.70 71 -100.65-106.81 6 PBT-18.66-44.95 58 -125.75-125.63 0 NP-19.29-46.09 58 -121.85-140.39 13 Powered by Capital Market - Live
Max India will hold a meeting of the Board of Directors of the Company on 28 May 2026.
Net Loss of Max India reported to Rs 42.85 crore in the quarter ended December 2025 as against net loss of Rs 44.60 crore during the previous quarter ended December 2024. Sales rose 24.06% to Rs 43.10 crore in the quarter ended December 2025 as against Rs 34.74 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales43.1034.74 24 OPM %-82.88-85.32 - PBDT-32.46-26.78 -21 PBT-38.55-31.81 -21 NP-42.85-44.60 4 Powered by Capital Market - Live
Max India will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live
Max India has allotted 12,500 equity shares under ESOP on 09 January 2026. Consequent to the aforesaid allotment, the issued, subscribed and paid-up capital of the Company stand increased from Rs 52,45,03,620 (comprising of 5,24,50,362 equity shares of of Rs 10/- each) to Rs.52,46,28,620 (comprising of 5,24,62,862 equity shares of Rs 10/- each).Powered by Capital Market - Live
AGEasy, the consumer products brand under Antara Senior Care'India's most comprehensive and integrated senior-care ecosystem'today announced the launch of its specialised Gut Care Range, developed in partnership with Wellbeing Nutrition, a leader in clean-label, science-backed nutraceuticals. Speaking about the launch, Ishaan Khanna, CEO, Antara Assisted Care Services, said, 'Gut health is foundational for seniors. Scientific literature shows that it influences immunity, inflammation, metabolic parameters and even cognitive function. With AGEasy's understanding of senior needs and Wellbeing Nutrition's scientific rigor, we have created a range that addresses the unique requirements of the ageing gut. The AGEasy Gut Care Range provides sustained, reliable support for concerns like acidity, constipation, bloating and overall digestive balance. At AGEasy, our mission is to enable self-care that is effortless, effective and joyful for seniors.'Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 12.39%, vs industry avg of 18.03%
Over the last 5 years, market share decreased from 0.29% to 0.22%